Suppression of HER2/HER3-Mediated Growth of Breast Cancer Cells with Combinations of GDC-0941 PI3K Inhibitor, Trastuzumab, and PertuzumabEvelyn Yao, Klaus P. Hoeflich, Si Tuen Lee-Hoeflich et al.|Clinical Cancer Research|2009Cited by 124